TG THERAPEUTICS, INC. (TGTX) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
49/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 9 wins, 3 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q23/3 |
WinTGTX / S&P 65.38% / 15.20% |
WinTGTX / S&P 76.08% / 15.00% |
WinTGTX / S&P 643.24% / 50.40% |
| 2026-Q13/3 |
WinTGTX / S&P 11.44% / -4.33% |
WinTGTX / S&P 81.26% / 11.30% |
WinTGTX / S&P 1095.83% / 27.70% |
| 2025-Q42/3 |
LoseTGTX / S&P -17.48% / 2.65% |
WinTGTX / S&P 87.32% / 9.00% |
WinTGTX / S&P 1885.71% / 13.40% |
| 2025-Q31/3 |
LoseTGTX / S&P 0.38% / 8.12% |
WinTGTX / S&P 100.88% / 4.61% |
LoseTGTX / S&P -2627.27% / 13.45% |
| 2025-Q21/3 |
LoseTGTX / S&P -8.72% / 10.94% |
WinTGTX / S&P 30.96% / 4.83% |
LoseTGTX / S&P -38.33% / 10.63% |
| 2025-Q12/3 |
WinTGTX / S&P 31.00% / -4.27% |
WinTGTX / S&P 33.54% / 4.98% |
LoseTGTX / S&P 9.09% / 10.57% |
| 2024-Q43/3 |
WinTGTX / S&P 28.69% / 2.41% |
WinTGTX / S&P 40.80% / 5.25% |
WinTGTX / S&P 1300.00% / 6.15% |
| 2024-Q32/3 |
WinTGTX / S&P 31.48% / 5.89% |
WinTGTX / S&P 39.53% / 5.89% |
LoseTGTX / S&P -76.09% / 6.11% |
| 2024-Q22/3 |
WinTGTX / S&P 16.96% / 4.28% |
WinTGTX / S&P 1341.63% / 5.38% |
LoseTGTX / S&P -141.38% / 5.12% |
| 2024-Q11/3 |
LoseTGTX / S&P -10.95% / 10.56% |
WinTGTX / S&P 3275.73% / 5.71% |
LoseTGTX / S&P -115.60% / 5.59% |
| 2023-Q42/3 |
WinTGTX / S&P 104.31% / 11.69% |
WinTGTX / S&P 8293.07% / 6.81% |
LoseTGTX / S&P -100.61% / 7.78% |
| 2023-Q31/3 |
LoseTGTX / S&P -66.34% / -3.27% |
WinTGTX / S&P 3676.56% / 7.52% |
LoseTGTX / S&P -74.01% / -5.03% |
| 2023-Q22/3 |
WinTGTX / S&P 65.16% / 8.74% |
WinTGTX / S&P 245.51% / 9.50% |
LoseTGTX / S&P -32.87% / -8.57% |
| 2023-Q11/3 |
WinTGTX / S&P 27.13% / 7.50% |
LoseTGTX / S&P 8.33% / 10.77% |
LoseTGTX / S&P -42.45% / -15.69% |
| 2022-Q41/3 |
WinTGTX / S&P 99.83% / 7.56% |
LoseTGTX / S&P -58.38% / 11.88% |
LoseTGTX / S&P -37.64% / -17.99% |
| 2022-Q32/3 |
WinTGTX / S&P 39.29% / -4.88% |
WinTGTX / S&P 14.05% / 13.47% |
LoseTGTX / S&P TGTX unavailable / -1.41% |
| 2022-Q21/3 |
LoseTGTX / S&P -55.31% / -16.10% |
WinTGTX / S&P 188.36% / 13.71% |
LoseTGTX / S&P TGTX unavailable / 11.04% |
| 2022-Q11/3 |
LoseTGTX / S&P -49.95% / -4.60% |
WinTGTX / S&P 772.33% / 15.97% |
LoseTGTX / S&P TGTX unavailable / 42.23% |
| 2021-Q41/3 |
LoseTGTX / S&P -42.91% / 11.03% |
WinTGTX / S&P 4300.66% / 15.00% |
LoseTGTX / S&P TGTX unavailable / 96.40% |
| 2021-Q31/3 |
LoseTGTX / S&P -14.20% / 0.58% |
WinTGTX / S&P 2798.68% / 10.77% |
LoseTGTX / S&P TGTX unavailable / 69.42% |
| 2021-Q21/3 |
LoseTGTX / S&P -19.52% / 8.55% |
WinTGTX / S&P 1488.16% / 6.58% |
LoseTGTX / S&P TGTX unavailable / 51.81% |
| 2021-Q11/3 |
LoseTGTX / S&P -7.34% / 6.17% |
WinTGTX / S&P 496.71% / -1.06% |
LoseTGTX / S&P TGTX unavailable / 7.39% |
| 2020-Q42/3 |
WinTGTX / S&P 94.39% / 12.15% |
WinTGTX / S&P 0.00% / -3.72% |
LoseTGTX / S&P TGTX unavailable / -33.42% |
| 2020-Q32/3 |
WinTGTX / S&P 37.37% / 8.93% |
WinTGTX / S&P 0.00% / -2.04% |
LoseTGTX / S&P TGTX unavailable / -27.10% |
| 2020-Q22/3 |
WinTGTX / S&P 97.97% / 20.54% |
WinTGTX / S&P 0.00% / -0.46% |
LoseTGTX / S&P TGTX unavailable / -27.11% |
| 2020-Q11/3 |
WinTGTX / S&P -11.35% / -19.60% |
LoseTGTX / S&P 0.00% / 3.47% |
LoseTGTX / S&P TGTX unavailable / -14.75% |
| 2019-Q41/3 |
WinTGTX / S&P 97.68% / 9.07% |
LoseTGTX / S&P 0.00% / 5.36% |
LoseTGTX / S&P TGTX unavailable / 2.99% |
| 2019-Q30/3 |
LoseTGTX / S&P -35.09% / 1.70% |
LoseTGTX / S&P 0.00% / 5.02% |
LoseTGTX / S&P TGTX unavailable / 0.21% |
| 2019-Q21/3 |
WinTGTX / S&P 7.59% / 4.30% |
LoseTGTX / S&P 0.00% / 6.64% |
LoseTGTX / S&P TGTX unavailable / 8.65% |
| 2019-Q11/3 |
WinTGTX / S&P 96.10% / 13.65% |
LoseTGTX / S&P 0.00% / 8.12% |
LoseTGTX / S&P TGTX unavailable / 14.29% |
| 2018-Q40/3 |
LoseTGTX / S&P -26.79% / -13.52% |
LoseTGTX / S&P TGTX unavailable / 9.05% |
LoseTGTX / S&P TGTX unavailable / 18.23% |
| 2018-Q30/3 |
LoseTGTX / S&P -57.41% / 7.71% |
LoseTGTX / S&P TGTX unavailable / 10.21% |
LoseTGTX / S&P TGTX unavailable / 19.06% |
| 2018-Q20/3 |
LoseTGTX / S&P -7.39% / 3.43% |
LoseTGTX / S&P TGTX unavailable / 9.03% |
LoseTGTX / S&P TGTX unavailable / 14.46% |
| 2018-Q11/3 |
WinTGTX / S&P 73.17% / -0.76% |
LoseTGTX / S&P TGTX unavailable / 7.68% |
LoseTGTX / S&P TGTX unavailable / 12.46% |
| 2017-Q40/3 |
LoseTGTX / S&P -30.80% / 6.64% |
LoseTGTX / S&P TGTX unavailable / 7.03% |
LoseTGTX / S&P TGTX unavailable / 13.82% |
| 2017-Q31/3 |
WinTGTX / S&P 17.91% / 4.48% |
LoseTGTX / S&P TGTX unavailable / 5.68% |
LoseTGTX / S&P TGTX unavailable / 17.57% |
| 2017-Q20/3 |
LoseTGTX / S&P -13.73% / 3.09% |
LoseTGTX / S&P TGTX unavailable / 4.83% |
LoseTGTX / S&P TGTX unavailable / 17.74% |
| 2017-Q11/3 |
WinTGTX / S&P 150.54% / 6.07% |
LoseTGTX / S&P TGTX unavailable / 3.67% |
LoseTGTX / S&P TGTX unavailable / 13.32% |
| 2016-Q40/3 |
LoseTGTX / S&P -39.92% / 3.82% |
LoseTGTX / S&P TGTX unavailable / 2.09% |
LoseTGTX / S&P TGTX unavailable / 7.05% |
| 2016-Q31/3 |
WinTGTX / S&P 27.72% / 3.85% |
LoseTGTX / S&P TGTX unavailable / 0.20% |
LoseTGTX / S&P TGTX unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | TGTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 89.98% | 20.78% |
| Annualized return | 89.98% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | TGTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 89.14% | 83.14% |
| Annualized return | 13.59% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | TGTX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 755.91% | 319.30% |
| Annualized return | 23.95% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |